• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

esRAGE 和 sRAGE 在儿童糖尿病肾病自然病程中的可能作用。

The possible role of esRAGE and sRAGE in the natural history of diabetic nephropathy in childhood.

机构信息

Department of Pediatrics, University of Chieti, Via dei Vestini 5, 66100, Chieti, Italy.

出版信息

Pediatr Nephrol. 2012 Feb;27(2):269-75. doi: 10.1007/s00467-011-1988-5. Epub 2011 Aug 26.

DOI:10.1007/s00467-011-1988-5
PMID:21870072
Abstract

The advanced glycation end products/receptor for advanced glycation end products (AGE-RAGE) pathway is a key mediator of glomerular changes in type 1 diabetes. We evaluated endogenous secretory (es)RAGE and soluble (s)RAGE concentrations in 64 pre-pubertal and pubertal normoalbuminuric patients with type 1 diabetes and compared the values with those of 62 controls matched for age, gender and Tanner pubertal stages. We also explored the possible association of their concentrations with early signs of diabetic nephropathy, defined as changes in kidney volume and estimated glomerular filtration rate (eGFR). Significantly lower concentrations of both esRAGE and sRAGE were documented in pre-pubertal (p = 0.003 and p = 0.001) and pubertal (p = 0.002 and p = 0.001) subjects with type 1 diabetes than in the controls. In both groups of patients with type 1 diabetes, the eGFR (pre-pubertal p = 0.01 and pubertal p = 0.01) and the mean value of kidney volume adjusted for body surface (pre-pubertal p = 0.003 and pubertal p = 0.002) were higher than those of the controls. The regression analysis showed an inverse relationship between esRAGE and body surface-adjusted mean kidney volume (p = 0.0004, r = -0.503). esRAGE and sRAGE concentrations were lower in normoalbuminuric youths with type 1 diabetes than in their healthy peers. The inverse association between esRAGE levels and early kidney alterations suggests a potential role of esRAGE in diabetic nephropathy.

摘要

糖基化终产物/糖基化终产物受体(AGE-RAGE)通路是 1 型糖尿病肾小球改变的关键介质。我们评估了 64 名青春期前和青春期的 1 型糖尿病伴正常白蛋白尿患者的内源性分泌型(es)RAGE 和可溶性(s)RAGE 浓度,并将这些值与 62 名年龄、性别和 Tanner 青春期阶段匹配的对照者进行比较。我们还探讨了它们的浓度与糖尿病肾病早期标志物(定义为肾脏体积和估算肾小球滤过率(eGFR)的变化)的可能关联。与对照组相比,1 型糖尿病的青春期前(p=0.003 和 p=0.001)和青春期(p=0.002 和 p=0.001)患者的 esRAGE 和 sRAGE 浓度均显著降低。在 1 型糖尿病的两组患者中,eGFR(青春期前 p=0.01 和青春期 p=0.01)和按体表面积校正的肾脏体积平均值(青春期前 p=0.003 和青春期 p=0.002)均高于对照组。回归分析显示,esRAGE 与按体表面积校正的平均肾脏体积呈负相关(p=0.0004,r=-0.503)。1 型糖尿病的正常白蛋白尿青少年的 esRAGE 和 sRAGE 浓度低于其健康同龄人。esRAGE 水平与早期肾脏改变之间的负相关提示 esRAGE 在糖尿病肾病中的潜在作用。

相似文献

1
The possible role of esRAGE and sRAGE in the natural history of diabetic nephropathy in childhood.esRAGE 和 sRAGE 在儿童糖尿病肾病自然病程中的可能作用。
Pediatr Nephrol. 2012 Feb;27(2):269-75. doi: 10.1007/s00467-011-1988-5. Epub 2011 Aug 26.
2
Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes.受体晚期糖基化终产物的表达增强与 2 型糖尿病患者循环中可溶性受体低表达有关。
Clin Sci (Lond). 2011 Jan;120(2):81-9. doi: 10.1042/CS20100256.
3
Soluble receptor for advanced glycation end products (sRAGE) and endogenous secretory RAGE (esRAGE) in amniotic fluid: modulation by infection and inflammation.羊水晚期糖基化终末产物可溶性受体(sRAGE)和内源性分泌型RAGE(esRAGE):受感染和炎症的调节
J Perinat Med. 2008;36(5):388-98. doi: 10.1515/JPM.2008.076.
4
Increased serum endogenous secretory receptor for advanced glycation end-product (esRAGE) levels in type 2 diabetic patients with decreased renal function.肾功能下降的2型糖尿病患者血清晚期糖基化终产物内源性分泌受体(esRAGE)水平升高。
Diabetes Res Clin Pract. 2008 Aug;81(2):196-201. doi: 10.1016/j.diabres.2008.04.013. Epub 2008 Jun 11.
5
Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes.可溶性晚期糖基化终产物受体而非内源性分泌型晚期糖基化终产物受体与2型糖尿病患者的蛋白尿有关。
Cardiovasc Diabetol. 2007 Mar 7;6:9. doi: 10.1186/1475-2840-6-9.
6
Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial.总可溶性及内源性晚期糖基化终产物受体作为 2 型糖尿病患者冠心病风险预测生物标志物的研究:来自 CARDS 试验的分析。
Diabetes. 2011 Sep;60(9):2379-85. doi: 10.2337/db11-0291. Epub 2011 Jul 19.
7
Two soluble isoforms of receptors for advanced glycation end products (RAGE) in carotid atherosclerosis: the difference of soluble and endogenous secretory RAGE.晚期糖基化终末产物受体(RAGE)的两种可溶性亚型在颈动脉粥样硬化中的作用:可溶性RAGE与内源性分泌型RAGE的差异
J Stroke Cerebrovasc Dis. 2014 Nov-Dec;23(10):2540-2546. doi: 10.1016/j.jstrokecerebrovasdis.2014.05.037. Epub 2014 Oct 3.
8
Endogenous secretory RAGE but not soluble RAGE is associated with carotid atherosclerosis in type 1 diabetes patients.内源性分泌型晚期糖基化终末产物受体而非可溶性晚期糖基化终末产物受体与1型糖尿病患者的颈动脉粥样硬化有关。
Diab Vasc Dis Res. 2008 Sep;5(3):190-7. doi: 10.3132/dvdr.2008.031.
9
Effect of insulin on the soluble receptor for advanced glycation end products (RAGE).胰岛素对晚期糖基化终产物可溶性受体(RAGE)的影响。
Diabet Med. 2013 Jun;30(6):702-9. doi: 10.1111/dme.12166. Epub 2013 Apr 4.
10
Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications.1型糖尿病患者内源性分泌性晚期糖基化终产物受体减少:其与糖尿病血管并发症的可能关联。
Diabetes Care. 2005 Nov;28(11):2716-21. doi: 10.2337/diacare.28.11.2716.

引用本文的文献

1
Advances in understanding and treating diabetic kidney disease: focus on tubulointerstitial inflammation mechanisms.理解和治疗糖尿病肾病的进展:聚焦于肾小管间质性炎症机制。
Front Endocrinol (Lausanne). 2023 Oct 4;14:1232790. doi: 10.3389/fendo.2023.1232790. eCollection 2023.
2
The Impact of Advanced Glycation End-Products (AGEs) on Proliferation and Apoptosis of Primary Stem Cells: A Systematic Review.晚期糖基化终末产物(AGEs)对原代干细胞增殖和凋亡的影响:一项系统综述
Stem Cells Int. 2020 Nov 14;2020:8886612. doi: 10.1155/2020/8886612. eCollection 2020.
3
Deletion of the formin Diaph1 protects from structural and functional abnormalities in the murine diabetic kidney.

本文引用的文献

1
Implications for kidney disease in obese children and adolescents.肥胖儿童和青少年的肾脏疾病的影响。
Pediatr Nephrol. 2011 May;26(5):749-58. doi: 10.1007/s00467-010-1659-y. Epub 2011 Feb 11.
2
Reduced endogenous secretory receptor for advanced glycation end products (esRAGE) in young people with Type 1 diabetes developing microalbuminuria.1 型糖尿病患者发生微量白蛋白尿时,其年轻人群中内源性晚期糖基化终产物受体(esRAGE)减少。
Diabet Med. 2009 Aug;26(8):815-9. doi: 10.1111/j.1464-5491.2009.02761.x.
3
Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications.
缺失形成蛋白 Diaph1 可保护糖尿病小鼠肾脏的结构和功能异常。
Am J Physiol Renal Physiol. 2018 Dec 1;315(6):F1601-F1612. doi: 10.1152/ajprenal.00075.2018. Epub 2018 Aug 22.
4
Blockade of HMGB1 Attenuates Diabetic Nephropathy in Mice.高迁移率族蛋白 B1 阻断减轻糖尿病肾病小鼠模型的肾脏损伤。
Sci Rep. 2018 May 29;8(1):8319. doi: 10.1038/s41598-018-26637-5.
5
Soluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year follow-up study.可溶性晚期糖基化终末产物受体与1型糖尿病青年患者的动脉粥样硬化:一项5年随访研究。
Cardiovasc Diabetol. 2015 Sep 25;14:126. doi: 10.1186/s12933-015-0292-2.
6
Targeting of receptor for advanced glycation end products suppresses cyst growth in polycystic kidney disease.靶向晚期糖基化终产物受体可抑制多囊肾病中的囊肿生长。
J Biol Chem. 2014 Mar 28;289(13):9254-62. doi: 10.1074/jbc.M113.514166. Epub 2014 Feb 10.
7
Serum levels of receptors for advanced glycation end products in normal-weight and obese children born small and large for gestational age.正常体重和肥胖的出生体重小于或大于胎龄儿的血清晚期糖基化终产物受体水平。
Diabetes Care. 2012 Jun;35(6):1361-3. doi: 10.2337/dc11-2302. Epub 2012 Apr 17.
多个调节层次决定了 AGE(糖基化终产物)受体(RAGE)在炎症、免疫反应和糖尿病及其并发症中的共同土壤作用。
Diabetologia. 2009 Nov;52(11):2251-63. doi: 10.1007/s00125-009-1458-9. Epub 2009 Jul 28.
4
Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes.血清内源性分泌型晚期糖基化终末产物受体水平是1型糖尿病患者颈动脉粥样硬化进展的独立危险因素。
Atherosclerosis. 2009 May;204(1):288-92. doi: 10.1016/j.atherosclerosis.2008.08.026. Epub 2008 Sep 2.
5
Diabetic nephropathy in children and adolescents.儿童及青少年糖尿病肾病
Pediatr Nephrol. 2008 Apr;23(4):507-25. doi: 10.1007/s00467-007-0583-2. Epub 2007 Oct 17.
6
Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes.可溶性晚期糖基化终产物受体而非内源性分泌型晚期糖基化终产物受体与2型糖尿病患者的蛋白尿有关。
Cardiovasc Diabetol. 2007 Mar 7;6:9. doi: 10.1186/1475-2840-6-9.
7
Endogenous secretory receptor for advanced glycation endproducts levels are correlated with serum pentosidine and CML in patients with type 1 diabetes.1型糖尿病患者体内晚期糖基化终末产物内源性分泌受体水平与血清戊糖苷和慢性粒细胞白血病相关。
Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):253-4. doi: 10.1161/01.ATV.0000251533.18013.67.
8
Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.2型糖尿病患者血清晚期糖基化终产物可溶性受体水平与循环晚期糖基化终产物之间的关联
Diabetologia. 2006 Nov;49(11):2756-62. doi: 10.1007/s00125-006-0394-1. Epub 2006 Sep 13.
9
Persistent renal hypertrophy and faster decline of glomerular filtration rate precede the development of microalbuminuria in type 1 diabetes.持续性肾肥大和肾小球滤过率更快下降先于1型糖尿病患者微量白蛋白尿的发生。
Diabetes. 2006 Sep;55(9):2620-5. doi: 10.2337/db06-0592.
10
Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes.晚期糖基化终末产物受体参与糖尿病血管生成反应受损过程。
Diabetes. 2006 Aug;55(8):2245-55. doi: 10.2337/db05-1375.